Financial Instruments - Schedule of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 229,488	$ 218,392
Unrealized Gain	140	78
Unrealized Losses	(867)	(2,544)
Fair Value	228,761	215,926
Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	199,084	184,321
Unrealized Gain	115	75
Unrealized Losses	(819)	(2,344)
Fair Value	198,380	182,052
U.S Treasury and Agency Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	30,404	34,071
Unrealized Gain	25	3
Unrealized Losses	(48)	(200)
Fair Value	30,381	$ 33,874
Cash and Cash Equivalents [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	1,213
Unrealized Gain	0
Unrealized Losses	(1)
Fair Value	1,212
Cash and Cash Equivalents [Member] | Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	1,213
Unrealized Gain	0
Unrealized Losses	(1)
Fair Value	$ 1,212